Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Efficacy and safety of danuglipron (PF-06882961) in adults with obesity: A randomized, placebo-controlled, dose-ranging phase 2b study.
Journal: Diabetes, obesity & metabolism
Published: December 22, 2024
Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism.
Journal: Journal of the Endocrine Society
Published: November 30, 2022
Risk of Chronic Kidney Disease and Estimated Glomerular Filtration Rate Decline in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort Study.
Journal: Advances in therapy
Published: November 24, 2020
Five-year Estimated Glomerular Filtration Rate in Patients With Hypoparathyroidism Treated With and Without rhPTH(1-84).
Journal: The Journal of clinical endocrinology and metabolism
Published: November 06, 2019
Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism.
Journal: The Journal of clinical endocrinology and metabolism
Published: April 30, 2019
Case 32-2016. A 20-Year-Old Man with Gynecomastia.
Journal: The New England journal of medicine
Published: November 01, 2016
Proton beam therapy for medulloblastoma - Author's reply.
Journal: The Lancet. Oncology
Published: April 06, 2016
Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.
Journal: The Journal of clinical investigation
Published: March 03, 2015
Anosmia in a 9-year-old boy.
Journal: JAMA otolaryngology-- head & neck surgery
Published: September 27, 2014
Last Updated: 09/26/2026